The precision cancer therapy developer, which counts Sanofi as a significant shareholder, floated at the top of an upsized range and saw its price continue to rise post-IPO.

Existing backer M12 reinvested in Innovaccer, pushing the total raised by the healthcare data management platform past the $120m mark.

Parkwalk Advisors is lining up investment to fund series C rounds for 10 of its portfolio companies, including spinouts of the universities of Oxford and Cambridge.

The fourth fund of ULB’s venture unit now stands at $41.2m having extended its investment purview to include spinouts in Quebec.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Chernin Group has returned for the meditation platform's $93m series C round, while Bennett Coleman & Co took part as a new investor.

VR mental health software developer Oxford VR secured the return of both OUI and OSI to increase its funding to more than $17m.

Biopsy verification technology developer Strand Diagnostics had raised $7.5m of a commitment from Nantworks originally slated to reach $30m.

D1 Capital Partners has led a series E round for Outset Medical, pushing the OSU dialysis device spinout’s overall funding to more than $430m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.